Japan to Add Shingles Vaccination to National Immunization Program in 2025

88
2
Japan to Add Shingles Vaccination to National Immunization Program in 2025

Shingles Vaccination to be Added to Japan's National Immunization Program

In a move to combat the rising cases of shingles, a common and painful condition affecting older adults, the Japanese health ministry will be adding the shingles vaccination to the national immunization program starting in fiscal year 2025. This will make individuals aged 65 eligible for the vaccine, with a portion of the cost covered by public funds.

For those who have already passed the age of 65, the program will include individuals aged 66 and above for the first five years. This phased approach ensures that individuals most at risk of developing shingles are prioritized.

Shingles, also known as herpes zoster, is characterized by burning or stabbing pain accompanied by a blistering rash that typically follows a nerve pathway on the body or face. Up to 50% of patients experience lingering nerve pain for months or even years, making it a debilitating condition.

a live vaccine requiring a single dose and a recombinant vaccine requiring two doses. These vaccines are currently available to individuals aged 50 and older, as well as those at least 18 who are at higher risk of developing the disease due to immune deficiency and other conditions. However, under the existing program, individuals must cover the full cost unless their local government provides a subsidy.

The new initiative aims to vaccinate individuals at age 65, helping to ensure that acquired immunity peaks around the age of 70, according to the ministry. This will significantly reduce the burden of shingles cases in the older population. The program also includes individuals aged 60 to 64 who have weakened immunity due to HIV infection.

Shingles and chickenpox are caused by the same virus. After a patient recovers from chickenpox, a common childhood disease, the virus remains dormant in the nervous system and can reactivate later in life, particularly when the immune system is weakened. It is estimated that one in three people will experience shingles by the age of 80.

By adding the shingles vaccination to the national immunization program, Japan is taking a proactive step towards protecting its older population from this painful and debilitating condition. This initiative will not only improve the quality of life for individuals but also reduce the economic burden associated with shingles treatment and management.